Drug manufacturers - Availability of investigational drugs, biological products, or devices - Costs - Insurance coverage
N.D. Cent. Code § 23-48-02
in effect23-48-02. Drug manufacturers - Availability of investigational drugs, biological
products, or devices - Costs - Insurance coverage.
1. A manufacturer of an investigational drug, biological product, or device may make
available the manufacturer's investigational drug, biological product, or device to an
eligible patient pursuant to this chapter. This chapter does not require that a
manufacturer make available to an eligible patient an investigational drug, biological
product, or device.
2. A manufacturer may:
a. Provide to an eligible patient an investigational drug, biological product, or device
without receiving compensation; or
b. Require an eligible patient to pay the costs of, or the costs associated with, the
manufacture of the investigational drug, biological product, or device.
3. If an eligible patient dies while being treated by an investigational drug, biological
product, or device, the eligible patient's heirs are not liable for any outstanding debt
related to the treatment or lack of insurance due to the treatment.
Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://ndlegis.gov/cencode/t23c48.pdf#nameddest=23-48-02Fetched: 10/16/2026